The total return over the past 12 months is -76.12% vs. +16.94% for the S&P 500. So far it's up -63.46% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (76.12%) | (57.00%) | (58.44%) | N/A | N/A | N/A |
| Total Return CAGR | (76.12%) | (57.00%) | (58.44%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Dogwood Therapeutics, Inc. (DWTX)
| Year | Start price | End price | DWTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $4.16 | $1.52 | (63.46%) | +14.51% | (77.97%) |
| 2025 | $2.49 | $4.16 | +67.07% | +17.72% | +49.35% |
| 2024 | $14.38 | $2.49 | (82.68%) | +24.89% | (107.57%) |
| 2023 | $5.90 | $14.38 | +143.73% | +26.19% | +117.54% |
| 2022 | $127.88 | $5.90 | (95.39%) | (18.17%) | (77.22%) |
| 2021 | $187.75 | $127.88 | (31.89%) | +28.74% | (60.63%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
